Search for:
CytomX
Search for:
About
Overview
Vision & Mission
Our Values
Executive Team
Board of Directors
Scientific Advisory Board
Contact Us
Probody Therapeutics
Our Probody Approach
How Probody Therapeutics Work
A Versatile Platform
Scientific Publications & Presentations
Pipeline
Advancing a Pipeline
Lead Candidates
Clinical Trials
Access for HCPs/Patients
Partners
Opportunities
Current Partners
Investors & News
Corporate Profile
Press Releases
Events & Presentations
Scientific Publications
Corporate Governance
Stock Information
Financial & Filings
Analyst Coverage
Investor Resources
Culture & Careers
Overview
Xtraordinary Culture
Current Openings
Total Rewards Program
Corporate Amenities
Home
Terms of use
Privacy policy
Disclaimer for Twitter
Menu
Transforming lives with safer, more effective therapies.
Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-target Effects with Reduced Off-tumor Toxicity for Use in Immuno-Oncology
Clin Cancer Res
; Autio, KA., Boni, V., Humphrey, RW. and Naing, A., October 2019.